Recipients cannot choose between two COVID vaccine options for now: GoI
1.1 crore doses of Covishield from the Serum Institute of India and 55 lakh doses of Covaxin from Bharat Biotech - will be…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s announces Sputnik V meets primary endpoint of safety in Phase 2 trial in India
Dr Reddy’s submitted the phase 2 safety data for DCGI’s approval to continue phase 3 clinical trials
Blueprint for progress
Experts and veterans examine and explore strategies for India Pharma Inc to implement the lessons learnt from the COVID-19…
LASA gets WHO GMP certificate for Khed Unit in Ratnagiri
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene…
Bharat Biotech signs deal with Precisa Medicamentos for COVAXIN supply to Brazil
Supplies will be prioritised for the public market through a direct procurement by the Government of Brazil, private market will…
NPPA updates provisional list of pharma, med-devices companies’ overcharging cases
Gives 15 days to the concerned companies to submit relevant data for further evaluation
Boehringer Ingelheim, Enara Bio sign pact to discover novel shared antigens for cancer…
Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers
TA Associates acquires stake in OmniActive Health Technologies
Financial terms of the transaction were not disclosed
$30 bn sales forecast for Pfizer-BioNTech COVID-19 vaccine from 2020-2026: GlobalData
The main challenge for BNT-162b2 is the ultra-cold storage requirement of -80°C. The vaccine is likely to suffer poor uptake in…
KORSCH AND MEDELPHARM partner to introduce R&D equipment portfolio
New R&D-stage lineup addresses challenges from early-stage powder characterisation and formulation development to scale-up and…